Comments on: Despite Humira patent expiry, Abbvie is poised to remain a market leader in Crohn’s disease /comment/commentdespite-humira-patent-expiry-abbvie-is-poised-to-remain-a-market-leader-in-crohns-disease-5912840/ The leading site for news and procurement in the pharmaceutical industry Tue, 29 Aug 2017 17:30:00 +0000 hourly 1 https://wordpress.org/?v=6.6.2